paraneoplastic syndrome
A tumor can hurt you up close — by pressing on, invading, or blocking nearby structures. A paraneoplastic syndrome is harm done at a distance instead: the tumor releases a chemical messenger that travels through the bloodstream and causes problems in organs far from where the cancer sits. The damage is by remote control rather than by direct contact.
In endocrinology, the most important paraneoplastic syndromes are hormone-driven. A tumor secretes a hormone (or a hormone-like molecule) ectopically, and that substance produces a full-blown endocrine disorder somewhere else in the body. Because the hormone is the link, the symptoms can be classic endocrine ones — disturbed calcium, sodium, blood sugar, or cortisol — appearing in someone whose endocrine glands are themselves perfectly normal.
Spotting a paraneoplastic syndrome can be life-saving, because it sometimes surfaces before the underlying cancer has caused any local symptoms, acting as an early warning. Treating the hormone effect helps the patient feel better, but the lasting fix is treating the tumor itself: when the cancer is removed or shrunk, the misplaced hormone production — and the syndrome — often subsides.
Many squamous-cell lung cancers secrete a PTH-like protein that raises blood calcium; the patient develops confusion, constipation, and excessive thirst — a paraneoplastic hypercalcemia driven from afar by the tumor.
High calcium caused by a tumor far from the parathyroids.
Not every paraneoplastic syndrome is hormonal — some are caused by immune cross-reactions that affect nerves or muscle — but the endocrine ones, driven by ectopic hormone secretion, are among the most common and treatable.